DLX6 and gastric cancer: In other studies, downregulation of DLX6‐AS1 inhibited gastric cancer cell proliferation, migration, invasion, and EMT in vitro, through competing endogenous RNA (ceRNA) by binding miR‐204‐5p and upregulating OCT1 (Solute Carrier Family 22 Member 1).